EverSource Wealth Advisors’s Minerva Neurosciences NERV Stock Holding History

EverSource Wealth Advisors’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17	Buy	+5	New	+$21	﹤0.01%	4504

Other funds holding NERV

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

EverSource Wealth Advisors's NERV Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Minerva Neurosciences (NERV) in Q3 2026: 5 shares worth $17. The stake represents ﹤0.01% of the portfolio and ranks #4504 among its holdings.

9 funds tracked by Wall St. Rank hold NERV as of Q3 2026.

EverSource Wealth Advisors held 5 shares of Minerva Neurosciences worth $17 as of Q3 2026.
Minerva Neurosciences was a new EverSource Wealth Advisors position in Q3 2026.
Minerva Neurosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4504 holding.
9 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.